InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.
Case studies featuring "Light-out Factory", "Society 5.0" and developments in additive manufacturing, IIoT, industry 4.0 across aerospace, pharma, electronics, automotive, chemical industries are major highlights at CMT's Manufacturing Automation Asia on